Veradermics Inc (MANE) Annual Balance Sheets

Annual · GAAP · USD millions
Access MANE quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Veradermics Inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent21.77
Available-for-sale Securities, Debt Securities, Current MA120.10
Cash & Short-term Investments141.00
Prepaid Expense And Other Assets Current10.63
Total Current Assets152.49
Equipment/Property/Plant Net0.02
Other Assets, Noncurrent0.10
Total Assets152.62
Liabilities
Accounts Payable, Current AC2.13
Accrued Liabilities, Current AC6.98
Other Liabilities, Current0.05
Total Current Liabilities9.15
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent0.00
Total Liabilities9.16
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2.35
Retained Earnings / Accumulated Deficit-123.42
Other Equity1.91
Common Stockholder's Equity-119.17
Non-controlling interests & other-1.85
Total Stockholder's Equity-121.01
Liabilities & Stockholder's Equity152.62
4 historic quarters locked

Sign in to unlock the full Veradermics Inc balance sheet history.

About Veradermics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001827635-26-000013

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License